{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:37:05Z","timestamp":1791387425383,"version":"4.3.3"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nucl. Med."],"abstract":"<jats:p>Parathyroid disorders profoundly affect bone metabolism, often long before structural damage is apparent on conventional imaging. Positron emission tomography\/computed tomography (PET\/CT) has emerged as a transformative tool in dysparathyroidism, enabling visualization of early metabolic bone changes and accurate localization of parathyroid pathology. This review explores the pathophysiology of bone disease in hyper- and hypoparathyroidism and highlights the role of key PET radiotracers: fluorine-18 sodium fluoride ([18F]NaF), fluorine-18 fluorodeoxyglucose ([18F]FDG), fluorine-18 fluorocholine ([18F]FCH), gallium-68 prostate-specific membrane antigen ([68Ga]PSMA). Distinct imaging patterns, such as the [18F]NaF \u201csuperscan\u201d in secondary hyperparathyroidism and focal uptake in brown tumors, are discussed alongside tracer-specific strengths. Clinical applications including diagnosis, monitoring response to therapy, and prognostication are examined. We also consider emerging technologies such as artificial intelligence (AI)-assisted interpretation and positron emission tomography\/magnetic resonance imaging (PET\/MRI) fusion imaging. As PET\/CT becomes more accessible, it is likely to play an increasingly central role in the early detection and personalized management of parathyroid-related bone disease.<\/jats:p>","DOI":"10.3389\/fnume.2025.1645497","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T17:23:21Z","timestamp":1761240201000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["PET\/CT imaging of bone disorders in dysparathyroidism: a comprehensive review"],"prefix":"10.3389","volume":"5","author":[{"given":"E.","family":"Panagiotidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Angelidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Valotassiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Tsougos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Georgoulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. T.","family":"Zhang-Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16033","DOI":"10.1038\/nrdp.2016.33","article-title":"Primary hyperparathyroidism","volume":"2","author":"Bilezikian","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jocd.2012.11.005","article-title":"Asymptomatic primary hyperparathyroidism","volume":"16","author":"Silverberg","year":"2013","journal-title":"J Clin Densitom"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","article-title":"Clinical practice: primary hyperparathyroidism","volume":"365","author":"Marcocci","year":"2011","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2967\/jnumed.107.045592","article-title":"Skeletal PET with 18F-NaF: applying new technology to an old tracer","volume":"49","author":"Grant","year":"2008","journal-title":"J Nucl Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.2967\/jnumed.110.081787","article-title":"Molecular mechanisms of bone 18F-NaF deposition","volume":"51","author":"Czernin","year":"2010","journal-title":"J Nucl Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.23736\/S1824-4785.23.03529-6","article-title":"Detection, resection and cure: a systematic review and meta-analysis of 18F-choline PET in primary hyperparathyroidism","volume":"67","author":"Quak","year":"2023","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"B7","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1080\/02841850802314788","article-title":"Enhanced FDG uptake in brown tumors mimics multiple skeletal metastases in a patient with primary hyperparathyroidism","volume":"49","author":"Hsu","year":"2008","journal-title":"Acta Radiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.molmed.2004.12.004","article-title":"Osteoclast-derived activity in the coupling of bone formation to resorption","volume":"11","author":"Martin","year":"2005","journal-title":"Trends Mol Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1590\/0004-2730000003381","article-title":"Bone disease in primary hyperparathyroidism","volume":"58","author":"Bandeira","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","article-title":"Parathyroid hormone metabolism and signaling in health and chronic kidney disease","volume":"90","author":"Evenepoel","year":"2016","journal-title":"Kidney Int"},{"key":"B11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12022-020-09656-9","article-title":"Genomics and epigenomics in parathyroid neoplasia: from bench to surgical pathology practice","volume":"32","author":"Juhlin","year":"2021","journal-title":"Endocr Pathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1210\/jc.2015-3908","article-title":"Epidemiology and diagnosis of hypoparathyroidism","volume":"101","author":"Clarke","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1210\/jc.2012-2586","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1359\/jbmr.080803","article-title":"Dynamic and structural properties of the skeleton in hypoparathyroidism","volume":"23","author":"Rubin","year":"2008","journal-title":"J Bone Miner Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1210\/clinem\/dgad007","article-title":"Extended treatment with recombinant human parathyroid hormone (1-84) in adult patients with chronic hypoparathyroidism","volume":"108","author":"Rubin","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6504","DOI":"10.3390\/ijms22126504","article-title":"1\u2078F-sodium fluoride PET as a diagnostic modality for metabolic, autoimmune, and osteogenic bone disorders: cellular mechanisms and clinical applications","volume":"22","author":"Park","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"W64","DOI":"10.2214\/AJR.17.19110","article-title":"Skeletal metastases and benign mimics on NaF PET\/CT: a pictorial review","volume":"211","author":"Panagiotidis","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/jbmr.1862","article-title":"1\u2078F-fluoride PET as a noninvasive imaging biomarker for determining treatment efficacy of bone active agents at the hip: a prospective, randomized, controlled clinical study","volume":"28","author":"Frost","year":"2013","journal-title":"J Bone Miner Res"},{"key":"B19","first-page":"1650","article-title":"(18)F-fluoride PET for monitoring therapeutic response in paget\u2019s disease of bone","volume":"46","author":"Installe","year":"2005","journal-title":"J Nucl Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s00223-013-9762-5","article-title":"18F-fluoride positron emission tomography measurements of regional bone formation in hemodialysis patients with suspected adynamic bone disease","volume":"93","author":"Frost","year":"2013","journal-title":"Calcif Tissue Int"},{"key":"B21","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3390\/diagnostics5030290","article-title":"FDG PET\/CT of brown tumors in a patient with primary hyperparathyroidism","volume":"5","author":"Andersen","year":"2015","journal-title":"Diagnostics (Basel)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1097\/RLU.0000000000002921","article-title":"Brown tumors secondary to parathyroid carcinoma masquerading as skeletal metastases on 18F-FDG PET\/CT: a case report","volume":"45","author":"Tsushima","year":"2020","journal-title":"Clin Nucl Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"uaad003","DOI":"10.1093\/bjrcr\/uaad003","article-title":"Two cases of parathyroid carcinoma associated with multiple brown tumours","volume":"10","author":"Sakai","year":"2024","journal-title":"BJR Case Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.14341\/probl13543","article-title":"Genetic profiling of parathyroid tumours: lifting the veil of mystery","volume":"70","author":"Bagirova","year":"2024","journal-title":"Probl Endocrinol (Mosk"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0197465","DOI":"10.1371\/journal.pone.0197465","article-title":"Associations between GLUT expression and SUV values derived from FDG-PET in different tumors: a systematic review and meta-analysis","volume":"13","author":"Meyer","year":"2018","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3390\/diagnostics11081355","article-title":"Molecular imaging with 18F-FDG PET\/CT and 99mTc-MIBI SPECT\/CT in osteitis fibrosa cystica generalisata","volume":"11","author":"Holzgreve","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1097\/RLU.0000000000004011","article-title":"Benign parathyroid hyperplasia with incidental pulmonary seeding on 99mTc-MIBI scintigraphy and FDG PET\/CT","volume":"47","author":"Tsai","year":"2022","journal-title":"Clin Nucl Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1097\/RLU.0000000000004941","article-title":"Metabolic superscan on 1\u2078F-FDG PET\/CT in a patient with secondary hyperparathyroidism","volume":"49","author":"Mohd Rohani","year":"2024","journal-title":"Clin Nucl Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.2967\/jnumed.120.257303","article-title":"Assessment and comparison of 1\u2078F-fluorocholine PET and \u2079\u2079mtc-sestamibi scans in identifying parathyroid adenomas: a meta-analysis","volume":"62","author":"Whitman","year":"2021","journal-title":"J Nucl Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/MNM.0000000000000952","article-title":"Choline PET\/CT in parathyroid imaging: a systematic review","volume":"40","author":"Broos","year":"2019","journal-title":"Nucl Med Commun"},{"key":"B31","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1001\/jamaoto.2024.1421","article-title":"F18-choline PET\/CT or MIBI SPECT\/CT in the surgical management of primary hyperparathyroidism: a diagnostic randomized clinical trial","volume":"150","author":"Quak","year":"2024","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"B32","doi-asserted-by":"publisher","first-page":"10018","DOI":"10.1038\/s41598-025-10018-0","article-title":"Contribution of 1\u2078F-fluorocholine PET-CT to the preoperative localisation of parathyroid adenoma for the treatment of primary hyperparathyroidism","volume":"15","author":"Garnier","year":"2025","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s11604-024-01698-x","article-title":"1\u2078F-fluorocholine PET\/CT imaging in primary hyperparathyroidism after negative or inconclusive cervical ultrasonography and \u2079\u2079mtc-MIBI scintigraphy","volume":"43","author":"Pasini Nemir","year":"2025","journal-title":"Jpn J Radiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1007\/s00259-018-4011-1","article-title":"1\u2078F-Fluorocholine PET\/CT in the assessment of primary hyperparathyroidism compared with \u2079\u2079mtc-MIBI or \u2079\u2079mtc-tetrofosmin SPECT\/CT: a prospective dual-centre study in 100 patients","volume":"45","author":"Beheshti","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B35","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s00259-018-4147-4","article-title":"Additional value of integrated 18F-choline PET\/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile","volume":"46","author":"Piccardo","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B36","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1001\/jamaoto.2019.1415","article-title":"Usefulness of 18F-fluorocholine positron emission tomography-computed tomography in locating lesions in hyperparathyroidism: a systematic review","volume":"145","author":"Boccalatte","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"B37","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1097\/RLU.0000000000002814","article-title":"18F-Fluorocholine PET\/CT imaging of brown tumors in a patient with severe primary hyperparathyroidism","volume":"44","author":"Zhang-Yin","year":"2019","journal-title":"Clin Nucl Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3390\/diagnostics14151690","article-title":"Parathyroid adenoma detected in \u2076\u2078ga-PSMA PET\/CT but not in the dedicated imaging modalities","volume":"14","author":"Cieslewicz","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00259-018-4239-1","article-title":"Pitfalls in ga-68-PSMA-PET\/CT: incidental finding of parathyroid adenoma","volume":"46","author":"Pfob","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e565","DOI":"10.1097\/RLU.0000000000004896","article-title":"Incidental detection of parathyroid adenoma on 1\u2078F-PSMA PET\/CT","volume":"48","author":"Broos","year":"2023","journal-title":"Clin Nucl Med"},{"key":"B41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-0038-1625218","article-title":"PET With 1\u2078F-DOPA in the imaging of parathyroid adenoma in patients with primary hyperparathyroidism: a pilot study","volume":"45","author":"Lange-Nolde","year":"2006","journal-title":"Nuklearmedizin"},{"key":"B42","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s12149-020-01507-1","article-title":"18F-choline PET\/CT and PET\/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature","volume":"34","author":"Evangelista","year":"2020","journal-title":"Ann Nucl Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1007\/s00259-024-06846-z","article-title":"\u2076\u2078ga-trivehexin PET\/CT: a promising novel tracer for primary hyperparathyroidism","volume":"51","author":"Kuyumcu","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B44","doi-asserted-by":"publisher","first-page":"766851","DOI":"10.3389\/fonc.2021.766851","article-title":"\u2076\u2078ga-P15-041, a novel bone imaging agent for diagnosis of bone metastases","volume":"11","author":"Guo","year":"2021","journal-title":"Front Oncol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e4202","DOI":"10.1210\/clinem\/dgab258","article-title":"Utility of 18F-AlF-NOTA-octreotide PET\/CT in the localization of tumor-induced osteomalacia","volume":"106","author":"Long","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/jlcr.3896","article-title":"Preclinical evaluation of [11C]L-235 as a radioligand for positron emission tomography cathepsin K imaging in bone","volume":"64","author":"Bennacef","year":"2021","journal-title":"J Labelled Comp Radiopharm"},{"key":"B47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ki.2015.116","article-title":"Sclerostin and DKK1: new players in renal bone and vascular disease","volume":"88","author":"Evenepoel","year":"2015","journal-title":"Kidney Int"},{"key":"B48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00259-011-1950-4","article-title":"Estimation of regional bone metabolism from whole-body 1\u2078F-fluoride PET static images","volume":"39","author":"Siddique","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1245\/s10434-012-2507-3","article-title":"Preoperative localization strategies for primary hyperparathyroidism: an economic analysis","volume":"19","author":"Lubitz","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2967\/jnumed.114.151944","article-title":"The role of radionuclide imaging in the surgical management of primary hyperparathyroidism","volume":"56","author":"Hindi\u00e9","year":"2015","journal-title":"J Nucl Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00259-014-2837-0","article-title":"1\u2078F-Fluorocholine PET\/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study","volume":"41","author":"Lezaic","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cpet.2022.09.001","article-title":"Emerging role of 18F - NaF PET\/computed tomographic imaging in osteoporosis: a potential upgrade to the osteoporosis toolbox","volume":"18","author":"Sheppard","year":"2023","journal-title":"PET Clin"},{"key":"B53","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cpet.2012.04.001","article-title":"Quantitative PET imaging using (18)F sodium fluoride in the assessment of metabolic bone diseases and the monitoring of their response to therapy","volume":"7","author":"Blake","year":"2012","journal-title":"PET Clin"},{"key":"B54","doi-asserted-by":"publisher","first-page":"115296","DOI":"10.1016\/j.bone.2020.115296","article-title":"Correlation between 18F-sodium fluoride positron emission tomography and bone histomorphometry in dialysis patients","volume":"134","author":"Aaltonen","year":"2020","journal-title":"Bone"},{"key":"B55","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s12149-024-01991-9","article-title":"Validation of quantitative [18F]NaF PET uptake parameters in bone diseases: a systematic review","volume":"39","author":"de Ruiter","year":"2025","journal-title":"Ann Nucl Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"115351","DOI":"10.1016\/j.bone.2020.115351","article-title":"Assessment of femoral neck bone metabolism using 18F-sodium fluoride PET\/CT imaging","volume":"136","author":"Rhodes","year":"2020","journal-title":"Bone"},{"key":"B57","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/MNM.0000000000001786","article-title":"Review of artificial intelligence clinical applications in nuclear medicine","volume":"45","author":"Panagiotidis","year":"2024","journal-title":"Nucl Med Commun"},{"key":"B58","doi-asserted-by":"publisher","first-page":"249","DOI":"10.23736\/S1824-4785.23.03554-5","article-title":"Role of 18F-NaF PET\/CT in bone metastases","volume":"67","author":"Zhang-Yin","year":"2023","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"B59","doi-asserted-by":"publisher","first-page":"247","DOI":"10.23736\/S1824-4785.23.03576-4","article-title":"Current update and future applications of bone metastasis imaging: what\u2019s next?","volume":"67","author":"Panagiotidis","year":"2023","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"B60","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s13139-024-00900-2","article-title":"Time to shift to digital PET\/CT?","volume":"59","author":"Kwon","year":"2024","journal-title":"Nucl Med Mol Imaging"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s00259-021-05334-y","article-title":"The EANM practice guidelines for parathyroid imaging","volume":"48","author":"Petranovi\u0107 Ov\u010dari\u010dek","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B62","doi-asserted-by":"publisher","first-page":"S406","DOI":"10.1016\/j.jacr.2021.08.012","article-title":"ACR Appropriateness criteria\u00ae parathyroid adenoma","volume":"18","author":"Kranis","year":"2021","journal-title":"J Am Coll Radiol"}],"container-title":["Frontiers in Nuclear Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnume.2025.1645497\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T17:23:23Z","timestamp":1761240203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnume.2025.1645497\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":62,"alternative-id":["10.3389\/fnume.2025.1645497"],"URL":"https:\/\/doi.org\/10.3389\/fnume.2025.1645497","relation":{},"ISSN":["2673-8880"],"issn-type":[{"value":"2673-8880","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"article-number":"1645497"}}